Keywords: Breast, Breast, MRI-guided breast biopsyMRI-guided breast biopsy (MRBB) methods and clinicopathological outcomes may vary between institutions. To identify benchmark metrics to help define a successful MRBB program, we identified and systematically reviewed articles on MRBB outcomes through 04.01.2021. Random intercept logistic regression model was used to pool the data. We found that MRBB is an efficient, highly accurate technique with high technical success (99.05%, 95%CI:97.75%-99.60%), low false-negative (0.65%, 95%CI:0.29%-1.44%), and complication (2.45%, 95%CI:2.13%-2.81%) rates. Our findings can assist the development of evidence-based clinical guidelines on follow-up recommendations in benign-concordant lesions and a transparent discussion with patients on the consequences of having an MRBB.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords